Mark Creager

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication
    Mark A Creager
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Circulation 124:1765-73. 2011
  2. doi request reprint The Creating an Optimal Warfarin Nomogram (CROWN) Study
    Todd S Perlstein
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Thromb Haemost 107:59-68. 2012
  3. ncbi request reprint Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I
    Mark A Creager
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, Mass 02115, USA
    Circulation 108:1527-32. 2003
  4. doi request reprint A randomized trial of iloprost in patients with intermittent claudication
    Mark A Creager
    Department of Medicine, Division of Cardiology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Vasc Med 13:5-13. 2008
  5. ncbi request reprint Flow-mediated vasodilation is mediated by endothelium-derived nitric oxide
    Mark A Creager
    Harvard Medical School, Boston, Massachusetts, USA
    J Appl Physiol 99:1625. 2005
  6. ncbi request reprint Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics
    Peter H Stone
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Am Heart J 147:875-82. 2004
  7. doi request reprint Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P
    David A Morrow
    TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 158:335-341.e3. 2009
  8. ncbi request reprint Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness
    Christopher D Owens
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Vasc Surg 44:740-6. 2006
  9. ncbi request reprint The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass, USA
    Circulation 114:861-6. 2006
  10. ncbi request reprint The nonlipid effects of statins on endothelial function
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Trends Cardiovasc Med 16:156-62. 2006

Detail Information

Publications66

  1. doi request reprint Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication
    Mark A Creager
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Circulation 124:1765-73. 2011
    ....
  2. doi request reprint The Creating an Optimal Warfarin Nomogram (CROWN) Study
    Todd S Perlstein
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Thromb Haemost 107:59-68. 2012
    ..07), and the time to achieve stable therapeutic anticoagulation (p < 0.001). In conclusion, warfarin pharmacogenetic dosing can be optimised in real time utilising observed PK/PD information in an adaptive fashion...
  3. ncbi request reprint Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I
    Mark A Creager
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, Mass 02115, USA
    Circulation 108:1527-32. 2003
  4. doi request reprint A randomized trial of iloprost in patients with intermittent claudication
    Mark A Creager
    Department of Medicine, Division of Cardiology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Vasc Med 13:5-13. 2008
    ..039). Neither iloprost nor pentoxifylline enhanced quality of life. These results indicate that oral iloprost is not effective in improving exercise performance or quality of life in patients with PAD who have intermittent claudication...
  5. ncbi request reprint Flow-mediated vasodilation is mediated by endothelium-derived nitric oxide
    Mark A Creager
    Harvard Medical School, Boston, Massachusetts, USA
    J Appl Physiol 99:1625. 2005
  6. ncbi request reprint Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics
    Peter H Stone
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Am Heart J 147:875-82. 2004
    ....
  7. doi request reprint Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P
    David A Morrow
    TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 158:335-341.e3. 2009
    ..Because SCH 530348 does not interfere with other pathways for hemostasis, it is possible that SCH 530348 reduces thrombosis with less increase in bleeding than do other potent antiplatelet agents...
  8. ncbi request reprint Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness
    Christopher D Owens
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Vasc Surg 44:740-6. 2006
    ..The geometric and biomechanical changes that contribute to vein graft remodeling are not well established. We sought to measure patterns of adaptation in lower extremity vein grafts and assess their correlation with clinical outcomes...
  9. ncbi request reprint The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass, USA
    Circulation 114:861-6. 2006
    ..We encourage the USPSTF to reevaluate the extant data, add vascular specialty expertise to its review group, and reconsider its recommendation...
  10. ncbi request reprint The nonlipid effects of statins on endothelial function
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Trends Cardiovasc Med 16:156-62. 2006
    ..This review will discuss the nonlipid effects of statins on endothelial cell function to highlight other avenues of benefit conferred by these medications...
  11. ncbi request reprint Advanced glycation end products: sparking the development of diabetic vascular injury
    Alison Goldin
    Cardiovascular Division, Brigham and Women s Hospital and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
    Circulation 114:597-605. 2006
    ..Because of the emerging evidence about the adverse effects of AGEs on the vasculature of patients with diabetes, a number of different therapies to inhibit AGEs are under investigation...
  12. ncbi request reprint Family history of diabetes is a major determinant of endothelial function
    Allison B Goldfine
    Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    J Am Coll Cardiol 47:2456-61. 2006
    ..We evaluated whether endothelial dysfunction was present in nondiabetic persons with a family history (FH) of diabetes and assessed its relationship with insulin resistance and atherosclerosis risk factors...
  13. ncbi request reprint ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Sur
    Alan T Hirsch
    Circulation 113:e463-654. 2006
  14. ncbi request reprint Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Deepak L Bhatt
    Cleveland Clinic, Cleveland, USA
    N Engl J Med 354:1706-17. 2006
    ..Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events...
  15. ncbi request reprint Role of nitric oxide in the regulation of digital pulse volume amplitude in humans
    Anju Nohria
    Cardiovascular Div, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    J Appl Physiol 101:545-8. 2006
    ..The present study establishes a central role for nitric oxide in the augmentation of PVA during reactive hyperemia. The measurement of digital PVA-RH may indeed provide a simple means of assessing endothelial function in humans...
  16. pmc Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease
    Anju Nohria
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Circ Res 99:1426-32. 2006
    ..Inhibition of the Rho/Rho kinase pathway should provide a useful strategy to restore NO bioavailability in humans with atherosclerosis...
  17. pmc Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery
    Christopher D Owens
    Division of Vascular Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Vasc Surg 45:2-9; discussion 9. 2007
    ..We hypothesized that high levels of inflammatory markers would identify patients at increased risk for adverse events (graft failure, major cardiovascular events) after lower extremity bypass surgery...
  18. pmc Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004
    Todd S Perlstein
    Department of Medicine, Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Am J Med 121:781-788.e1. 2008
    ..Clinical data addressing the association of bilirubin with stroke are not available. We hypothesized that higher bilirubin levels would be associated with reduced stroke prevalence and improved stroke outcomes...
  19. pmc Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004
    Reena L Pande
    Brigham and Women s Hospital, Cardiovascular Division, 75 Francis St, A Bldg, 3rd Floor, Boston, MA 02115, USA
    Circulation 118:33-41. 2008
    ..We hypothesized that IR is associated with PAD and that the presence of IR would influence the association between C-reactive protein (CRP) and PAD, an association established predominantly in healthy individuals...
  20. doi request reprint Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk
    Aruna D Pradhan
    Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital and Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215 1204, USA
    Circulation 117:823-31. 2008
    ..Few large-scale prospective studies have critically assessed plasma-based factors as predictors of peripheral arterial disease (PAD), and comparative data between individual biomarkers and lipid levels are sparse, especially among women...
  21. ncbi request reprint ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and
    Spencer B King
    Circulation 116:98-124. 2007
  22. ncbi request reprint Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging
    Frank John Rybicki
    Department of Radiology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Int J Cardiovasc Imaging 24:529-33. 2008
    ....
  23. ncbi request reprint Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
    Todd S Perlstein
    Brigham and Women s Hospital, Cardiovascular Division, Harvard Medical School, Boston, MA 02115, USA
    Arterioscler Thromb Vasc Biol 28:166-72. 2008
    ..We hypothesized that higher levels of bilirubin would reduce susceptibility to peripheral arterial disease (PAD)...
  24. ncbi request reprint ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and
    Spencer B King
    J Am Coll Cardiol 50:82-108. 2007
  25. ncbi request reprint Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 49:1982-8. 2007
    ..The purpose of this study was to determine the possible benefit of dual antiplatelet therapy in patients with prior myocardial infarction (MI), ischemic stroke, or symptomatic peripheral arterial disease (PAD)...
  26. ncbi request reprint Endothelial function varies according to insulin resistance disease type
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Diabetes Care 30:1226-32. 2007
    ....
  27. ncbi request reprint Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study
    Peter H Stone
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Circulation 111:1747-55. 2005
    ..Lipid lowering with statins prevents adverse cardiac events. Both lipid-lowering and antioxidant therapies may favorably affect vasomotor function and thereby improve ischemia...
  28. ncbi request reprint Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease
    Emile R Mohler
    Cardiovascular Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Circulation 108:1481-6. 2003
    ..The purpose of this study was to determine whether cholesterol lowering with atorvastatin improves walking performance in patients with intermittent claudication...
  29. ncbi request reprint Endothelin-1 and vascular tone in subjects with atherogenic risk factors
    Anju Nohria
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Hypertension 42:43-8. 2003
    ..These results indicate that ET-1 contributes more to the pathophysiology of hypertension than of other risk factors in subjects without overt atherosclerosis...
  30. ncbi request reprint Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Am J Physiol Heart Circ Physiol 285:H2392-8. 2003
    ..Oral antioxidant therapy improves EDV in T1 but not T2 diabetes. These results are consistent with the lack of clinical benefit in studies that have included primarily T2 diabetic patients...
  31. ncbi request reprint Pharmacotherapy and behavioral intervention for peripheral arterial disease
    Jeanne Doyle
    Cardiovascular Division, Brigham and Women s Hospital, Boston, MA, USA
    Rev Cardiovasc Med 4:18-24. 2003
    ....
  32. ncbi request reprint Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II
    Thomas F Luscher
    Cardiology, Cardiovascular Center, University Hospital and Cardiovascular Research, Institute of Physiology, University Zurich, Switzerland
    Circulation 108:1655-61. 2003
  33. ncbi request reprint Direct effect of ethanol on human vascular function
    Ahmed Tawakol
    Cardiac Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Am J Physiol Heart Circ Physiol 286:H2468-73. 2004
    ..None of these effects appear to be mediated by an increase in nitric oxide bioavailability, thus disputing findings from preclinical models...
  34. ncbi request reprint Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function
    Scott Kinlay
    Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 43:629-34. 2004
    ..We tested whether long-term administration of antioxidant vitamins C and E improves coronary and brachial artery endothelial function in patients with coronary artery disease (CAD)...
  35. ncbi request reprint The contribution of nitric oxide to exercise hyperemia in the human forearm
    Mary Beth Gordon
    Harvard Medical School 03, Boston, MA, USA
    Vasc Med 7:163-8. 2002
    ..This study indicates that NO is not a major regulator of peak limb blood flow measured immediately after cessation of dynamic exercise. The contribution of NO to exercise hyperemia is limited to the recovery period after exercise...
  36. ncbi request reprint Homocysteine impairs coronary microvascular dilator function in humans
    Ahmed Tawakol
    Departments of Medicine Cardiac Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Coll Cardiol 40:1051-58. 2002
    ..We sought to use positron emission tomography (PET) to test the hypothesis that hyperhomocysteinemia adversely effects coronary microvascular dilator function...
  37. ncbi request reprint Critical issues in peripheral arterial disease detection and management: a call to action
    Jill J F Belch
    Department of Medicine, Ninewells Hospitals and Medical School, Scotland
    Arch Intern Med 163:884-92. 2003
  38. ncbi request reprint Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA
    Circ Res 90:107-11. 2002
    ..These findings suggest that hyperglycemia impairs endothelial function, in part, via protein kinase Cbeta activation...
  39. pmc Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Circ Res 95:217-23. 2004
    ..These findings implicate a potential role for statin therapy to restore endothelial function and thereby investigate vascular disease in cigarette smokers...
  40. ncbi request reprint Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force
    Mary C Corretti
    Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland 21205 1595, USA
    J Am Coll Cardiol 39:257-65. 2002
    ....
  41. ncbi request reprint Diabetes and atherosclerosis: epidemiology, pathophysiology, and management
    Joshua A Beckman
    Leducq Center for Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    JAMA 287:2570-81. 2002
    ..Complications of atherosclerosis cause most morbidity and mortality in patients with diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy remains incompletely understood and underused...
  42. ncbi request reprint Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy
    William R Hiatt
    Department of Medicine, University of Colorado School of Medicine, Section of Vascular Medicine, and the Colorado Prevention Center, Denver, CO 80203, USA
    Vasc Med 9:18-25. 2004
    ..These data indicate that selective serotonin receptor blockade does not improve exercise tolerance or quality of life in individuals with claudication...
  43. ncbi request reprint Comparison of endothelial function in young men and women with a family history of premature coronary artery disease
    Naomi M Hamburg
    Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, 75 Francis Street, Boston, MA 02115, USA
    Am J Cardiol 94:783-5. 2004
    ....
  44. ncbi request reprint Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey
    Alan T Hirsch
    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Ste 300, 1300 S 2nd St, Minneapolis, MN 55454, USA
    Circulation 116:2086-94. 2007
    ..Nevertheless, public knowledge of PAD as a morbid and mortal disease has not been previously assessed...
  45. ncbi request reprint 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to devel
    Theodore D Fraker
    Circulation 116:2762-72. 2007
  46. ncbi request reprint Peripheral arterial disease
    Sonia S Anand
    McMaster University, Hamilton, Canada
    Am Fam Physician 65:2321-2. 2002
  47. ncbi request reprint 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to devel
    Theodore D Fraker
    J Am Coll Cardiol 50:2264-74. 2007
  48. ncbi request reprint 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaborat
    Elliott M Antman
    Circulation 117:296-329. 2008
  49. ncbi request reprint Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions
    Wendy Johnson
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Am J Physiol Heart Circ Physiol 283:H568-75. 2002
    ..Endothelin contributes to basal pulmonary and systemic vascular tone during normoxia, but does not mediate the additional pulmonary vasoconstriction induced by acute hypoxia...
  50. doi request reprint High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE
    Dimitris Mitsouras
    Cardiovascular Imaging Section, Department of Radiology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Magn Reson Med 59:650-4. 2008
    ....
  51. ncbi request reprint Angiotensin II contributes to arterial compliance in congestive heart failure
    Silvia G Lage
    Heart Institute, School of Medicine, University of Sao Paulo, Brazil
    Am J Physiol Heart Circ Physiol 283:H1424-9. 2002
    ..This favorable effect on the pulsatile component of afterload may contribute to the improvement in left ventricular performance that occurs in patients with heart failure treated with angiotensin-converting enzyme inhibitors...
  52. ncbi request reprint Postgraduate training in vascular medicine: proposed requirements and standards
    Mark A Creager
    Harvard Medical School, Boston, MA, USA
    Vasc Med 8:47-52. 2003
  53. ncbi request reprint The relationship of cigarette smoking to peripheral arterial disease
    Jeffrey T Lu
    Cardiovascular Division, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Rev Cardiovasc Med 5:189-93. 2004
    ..Healthcare providers must enhance their efforts and target smoking cessation as a modifiable risk factor in patients with PAD and other manifestations of atherosclerosis...
  54. ncbi request reprint A focus on risk factor management
    Jill J F Belch
    Vasc Med 9:169-70. 2004
  55. ncbi request reprint ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on vascular medicine and catheter-based peripheral vascular interventions. A report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical
    Mark A Creager
    Vasc Med 9:233-48. 2004
  56. ncbi request reprint ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competenc
    Matthew J Budoff
    J Am Coll Cardiol 46:383-402. 2005
  57. ncbi request reprint A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am Heart J 150:401. 2005
    ..We sought to characterize the risk factors and treatments of a diverse contemporary population of patients with atherothrombosis...
  58. ncbi request reprint ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vas
    Alan T Hirsch
    J Am Coll Cardiol 47:1239-312. 2006
  59. ncbi request reprint Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy
    Mark A Creager
    Circulation 109:2634-42. 2004
  60. ncbi request reprint Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association
    David P Faxon
    Circulation 109:2595-604. 2004
  61. ncbi request reprint Special communication: mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health
    Alan T Hirsch
    Division of Epidemiology, University of Minnesota School of Public Health, and Vascular Medicine Program, Minneapolis Heart Institute, Rochester, MN, USA
    Angiology 55:233-42. 2004
    ....
  62. ncbi request reprint Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health
    Alan T Hirsch
    Division of Epidemiology, University of Minnesota School of Public Health, and Vascular Medicine Program, Minneapolis Heart Institute, Rochester, MN, USA
    Vasc Endovascular Surg 38:121-30. 2004
    ....
  63. ncbi request reprint ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical C
    Mark A Creager
    J Am Coll Cardiol 44:941-57. 2004
  64. ncbi request reprint ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society
    Alan T Hirsch
    J Vasc Interv Radiol 17:1383-97; quiz 1398. 2006
  65. ncbi request reprint Arginine and endothelial and vascular health
    Heather L Gornik
    Vascular Medicine Section, Cardiovascular Division, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Nutr 134:2880S-2887S; discussion 2895S. 2004
    ..Given the promising findings of early studies of L-arginine as a potential therapy for cardiovascular disorders, large-scale clinical trials are warranted...
  66. doi request reprint Task force 11: training in vascular medicine and peripheral vascular catheter-based interventions endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Vascular Medicine
    Mark A Creager
    J Am Coll Cardiol 51:398-404. 2008

Research Grants10

  1. Inflammation and Insulin Resistance in PAD
    Mark Creager; Fiscal Year: 2007
    ..It is anticipated that the findings from this investigation will uncover novel pathophysiologic mechanisms and foster a new paradigm for the treatment of PAD. ..
  2. Clinical and Research Training Program for Academic Vascular Medicine Specialists
    Mark Creager; Fiscal Year: 2007
    ..As a consequence of the intensive clinical and research training integrated in this program, we are confident that we will successfully prepare future academic leaders in the field of Vascular Medicine. ..
  3. Targeting Inflammation to Improve Endothelial Function in Type 2 Diabetes: A Subs
    Mark A Creager; Fiscal Year: 2010
    ..End of Abstract) ..